Presenilin-1 mutations and Alzheimer's disease

Proceedings of the National Academy of Sciences of the United States of America

Volumn 114, Issue 4, 2017, Pages 629-631

  Kelleher, Raymond J ^a,b   Shen, Jie ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; GAMMA SECRETASE; PRESENILIN 1; AMYLOID PRECURSOR PROTEIN; PRESENILIN 2;

ALZHEIMER DISEASE; ENZYME ACTIVITY; GENE MUTATION; HUMAN; IN VITRO STUDY; NOTE; PRIORITY JOURNAL; GENETICS; MUTATION;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; HUMANS; MUTATION; PRESENILIN-1; PRESENILIN-2;

EID: 85010689252     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1619574114     Document Type: Note

References (20)

1. Sun L, Zhou R, Yang G, Shi Y (2017) Analysis of 138 pathogenic mutations in presenilin-1 on the in vitro production of Aβ42 and Aβ40 peptides by γ-secretase. Proc Natl Acad Sci USA 114:E476-E485.
2. Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics. Science 297(5580):353-356.
3. Shen J, Kelleher RJ, 3rd (2007) The presenilin hypothesis of Alzheimer's disease: Evidence for a loss-of-function pathogenic mechanism. Proc Natl Acad Sci USA 104(2):403-409.
4. Duff K, et al. (1996) Increased amyloid-beta42(43) in brains of mice expressing mutant presenilin 1. Nature 383(6602):710-713.
5. Scheuner D, et al. (1996) Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nat Med 2(8):864-870.
6. Borchelt DR, et al. (1996) Familial Alzheimer's disease-linked presenilin 1 variants elevate Abeta1-42/1-40 ratio in vitro and in vivo. Neuron 17(5):1005-1013.
7. Selkoe DJ, Hardy J (2016) The amyloid hypothesis of Alzheimer's disease at 25 years. EMBO Mol Med 8(6):595-608.
8. Saura CA, et al. (2004) Loss of presenilin function causes impairments of memory and synaptic plasticity followed by age-dependent neurodegeneration. Neuron 42(1):23-36.
9. Wines-Samuelson M, et al. (2010) Characterization of age-dependent and progressive cortical neuronal degeneration in presenilin conditional mutant mice. PLoS One 5(4):e10195.
10. Watanabe H, Xia D, Kanekiyo T, Kelleher RJ, 3rd, Shen J (2012) Familial frontotemporal dementia-associated presenilin-1 c.548G>T mutation causes decreased mRNA expression and reduced presenilin function in knock-in mice. J Neurosci 32(15):5085-5096.
11. Heilig EA, Xia W, Shen J, Kelleher RJ, 3rd (2010) Apresenilin-1 mutation identified in familial Alzheimer disease with cotton wool plaques causes a nearly complete loss of gamma-secretase activity. J Biol Chem 285(29):22350-22359.
12. Heilig EA, Gutti U, Tai T, Shen J, Kelleher RJ, 3rd (2013) Trans-dominant negative effects of pathogenic PSEN1 mutations on γ-secretase activity and Aβ production. J Neurosci 33(28):11606-11617.
13. Xia D, et al. (2015) Presenilin-1 knockin mice reveal loss-of-function mechanism for familial Alzheimer's disease. Neuron 85(5):967-981.
14. Xia D, Kelleher RJ, 3rd, Shen J (2016) Loss of Aβ43 production caused by presenilin-1 mutations in the knockin mouse brain. Neuron 90(2):417-422.
15. Bai XC, et al. (2015) An atomic structure of human γ-secretase. Nature 525(7568):212-217.
16. Pastor P, et al. (2003) Apolipoprotein Eepsilon4 modifies Alzheimer's disease onset in an E280A PS1 kindred. Ann Neurol 54(2):163-169.
17. Vélez JI, et al. (2016) APOE∗E2 allele delays age of onset in PSEN1 E280A Alzheimer's disease. Mol Psychiatry 21(7):916-924.
18. Ryman DC, et al.; Dominantly Inherited Alzheimer Network (2014) Symptom onset in autosomal dominant Alzheimer disease: A systematic review and meta-analysis. Neurology 83(3):253-260.
19. Wolfe MS (2007) When loss is gain: Reduced presenilin proteolytic function leads to increased Aβ42/Aβ40. Talking Point on the role of presenilin mutations in Alzheimer disease. EMBO Rep 8(2):136-140.
20. Zheng J, et al. (2012) Conditional deletion of Notch1 and Notch2 genes in excitatory neurons of postnatal forebrain does not cause neurodegeneration or reduction of Notch mRNAs and proteins. J Biol Chem 287(24):20356-20368.